Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

The overhead view is of me in a maze.” I don’t know what it says about me that the great Trey Anastasio and Tom Marshall of ...

Chiefs-Bills national anthem has Chris Jones in tears as Super Bowl demand made Despite Trump’s demand that the Fed cut rates ...

Here's what's new in Bay Area biz news to start your workweek: tech stocks on wild ride, empty S.F. office buildings, copper ...

DeepSeek's DeepThink R1 built a playable Pac-Man game in minutes with minimal input. We tested its reasoning, coding, and ...

(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...

The former CEO of American Aquafarms, Blue Harvest and High Liner has been brought in as a consultant for Pescanova USA ...

Simplify database management with Chat2DB, an AI-powered tool for SQL, data analysis, and real-time dashboards. Perfect for ...

Ohio State's Wexner Medical Center moved its Emergency Department entrance to facilitate inpatient tower construction.

It was a big ask, not to mention a big task, but over the course of the summer we (almost) made it through my carefully ...